Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02829437 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Observational Study on Endometrial Stromal Tumors

Study acronym: EST
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2025 to Dec 2026v10
  2. Primary and study completion dates: Dec 2024 to Dec 2025v9
  3. Primary and study completion dates: Aug 2023 to Dec 2024v8
  4. Primary completion date: Aug 2022 to Aug 2023v7
  5. 2 versions Re-verified since Jul 27, 2020, no change to tracked fieldsv5-v6
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Aug 2021 to Aug 2022
    • Study completion date: Aug 2022 to Aug 2023
    v4
  2. Site details revised at 1 of 13 sitesv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Aug 2016 to Oct 2016
    • Site details revised at 13 of 13 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Observational, retrospective and prospective study on Endometrial Stromal Tumor (EST)
Trial Details
NCT Number NCT02829437
Lead Sponsor Italian Sarcoma Group
Conditions
(from sponsor)		 Endometrial Stromal Tumors
Related terms Endometrial Stromal Tumors
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov